Impact of metabolic syndrome on the hospitalization rate of Crohn's disease patients seen at a tertiary care center: A retrospective cohort study

Paul Stephen Fitzmorris, Lisandro Damian Colantonio, Euriko Torrazza Perez, Ioana Smith, Donny Debajyoti Kakati, Talha Malik

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Background/Aims: Recent studies suggest that markers of mesenteric inflammation, such as increased adipose tissue, may be associated with poor outcomes in Crohn's disease (CD). This study's hypothesis is that CD patients with metabolic syndrome (MetS) have more CD-related hospitalizations than CD patients without MetS. Methods: We conducted a retrospective cohort study of CD patients seen from 2000 to 2012 at our tertiary care center. We analyzed crude and age-, sex- and duration of CD-adjusted incidence rate ratio (IRR) of CD-related hospitalization of those with MetS versus those without MetS. We also investigated possible associations between individual component conditions of MetS and rate of CD-related hospitalization. Results: A total of 868 CD patients were included. There were 37 (4%) patients with MetS at initial observation. After multi-variable adjustment, patients with MetS had a CD-related hospitalization rate twice that of those who did not have MetS. High triglycerides (TG), low high density lipoprotein (HDL) cholesterol and diabetes mellitus (DM) were associated with increased risk of CD-related hospitalization. Conclusions: CD patients with MetS have a higher rate of CD-related hospitalization compared to those without MetS. Hypertriglyceridemia, low HDL cholesterol and DM may be good markers of local and systemic inflammation as seen in CD.

Original languageEnglish (US)
Pages (from-to)257-262
Number of pages6
JournalDigestion
Volume91
Issue number3
DOIs
StatePublished - May 6 2015
Externally publishedYes

Fingerprint

Tertiary Care Centers
Crohn Disease
Hospitalization
Cohort Studies
Retrospective Studies
LDL Cholesterol
HDL Cholesterol
Diabetes Mellitus
Inflammation
Hypertriglyceridemia
Adipose Tissue
Triglycerides
Observation

Keywords

  • Crohn's disease
  • Diabetes mellitus
  • Dyslipidemia
  • Hospitalization rate
  • Hypertension
  • Inflammatory bowel disease
  • Inflammatory markers
  • Metabolic co-morbidities
  • Metabolic syndrome
  • Obesity

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Impact of metabolic syndrome on the hospitalization rate of Crohn's disease patients seen at a tertiary care center : A retrospective cohort study. / Fitzmorris, Paul Stephen; Colantonio, Lisandro Damian; Torrazza Perez, Euriko; Smith, Ioana; Kakati, Donny Debajyoti; Malik, Talha.

In: Digestion, Vol. 91, No. 3, 06.05.2015, p. 257-262.

Research output: Contribution to journalArticle

Fitzmorris, Paul Stephen ; Colantonio, Lisandro Damian ; Torrazza Perez, Euriko ; Smith, Ioana ; Kakati, Donny Debajyoti ; Malik, Talha. / Impact of metabolic syndrome on the hospitalization rate of Crohn's disease patients seen at a tertiary care center : A retrospective cohort study. In: Digestion. 2015 ; Vol. 91, No. 3. pp. 257-262.
@article{708e21f430f74bcc962050fa6483afa6,
title = "Impact of metabolic syndrome on the hospitalization rate of Crohn's disease patients seen at a tertiary care center: A retrospective cohort study",
abstract = "Background/Aims: Recent studies suggest that markers of mesenteric inflammation, such as increased adipose tissue, may be associated with poor outcomes in Crohn's disease (CD). This study's hypothesis is that CD patients with metabolic syndrome (MetS) have more CD-related hospitalizations than CD patients without MetS. Methods: We conducted a retrospective cohort study of CD patients seen from 2000 to 2012 at our tertiary care center. We analyzed crude and age-, sex- and duration of CD-adjusted incidence rate ratio (IRR) of CD-related hospitalization of those with MetS versus those without MetS. We also investigated possible associations between individual component conditions of MetS and rate of CD-related hospitalization. Results: A total of 868 CD patients were included. There were 37 (4{\%}) patients with MetS at initial observation. After multi-variable adjustment, patients with MetS had a CD-related hospitalization rate twice that of those who did not have MetS. High triglycerides (TG), low high density lipoprotein (HDL) cholesterol and diabetes mellitus (DM) were associated with increased risk of CD-related hospitalization. Conclusions: CD patients with MetS have a higher rate of CD-related hospitalization compared to those without MetS. Hypertriglyceridemia, low HDL cholesterol and DM may be good markers of local and systemic inflammation as seen in CD.",
keywords = "Crohn's disease, Diabetes mellitus, Dyslipidemia, Hospitalization rate, Hypertension, Inflammatory bowel disease, Inflammatory markers, Metabolic co-morbidities, Metabolic syndrome, Obesity",
author = "Fitzmorris, {Paul Stephen} and Colantonio, {Lisandro Damian} and {Torrazza Perez}, Euriko and Ioana Smith and Kakati, {Donny Debajyoti} and Talha Malik",
year = "2015",
month = "5",
day = "6",
doi = "10.1159/000380763",
language = "English (US)",
volume = "91",
pages = "257--262",
journal = "Digestion",
issn = "0012-2823",
publisher = "S. Karger AG",
number = "3",

}

TY - JOUR

T1 - Impact of metabolic syndrome on the hospitalization rate of Crohn's disease patients seen at a tertiary care center

T2 - A retrospective cohort study

AU - Fitzmorris, Paul Stephen

AU - Colantonio, Lisandro Damian

AU - Torrazza Perez, Euriko

AU - Smith, Ioana

AU - Kakati, Donny Debajyoti

AU - Malik, Talha

PY - 2015/5/6

Y1 - 2015/5/6

N2 - Background/Aims: Recent studies suggest that markers of mesenteric inflammation, such as increased adipose tissue, may be associated with poor outcomes in Crohn's disease (CD). This study's hypothesis is that CD patients with metabolic syndrome (MetS) have more CD-related hospitalizations than CD patients without MetS. Methods: We conducted a retrospective cohort study of CD patients seen from 2000 to 2012 at our tertiary care center. We analyzed crude and age-, sex- and duration of CD-adjusted incidence rate ratio (IRR) of CD-related hospitalization of those with MetS versus those without MetS. We also investigated possible associations between individual component conditions of MetS and rate of CD-related hospitalization. Results: A total of 868 CD patients were included. There were 37 (4%) patients with MetS at initial observation. After multi-variable adjustment, patients with MetS had a CD-related hospitalization rate twice that of those who did not have MetS. High triglycerides (TG), low high density lipoprotein (HDL) cholesterol and diabetes mellitus (DM) were associated with increased risk of CD-related hospitalization. Conclusions: CD patients with MetS have a higher rate of CD-related hospitalization compared to those without MetS. Hypertriglyceridemia, low HDL cholesterol and DM may be good markers of local and systemic inflammation as seen in CD.

AB - Background/Aims: Recent studies suggest that markers of mesenteric inflammation, such as increased adipose tissue, may be associated with poor outcomes in Crohn's disease (CD). This study's hypothesis is that CD patients with metabolic syndrome (MetS) have more CD-related hospitalizations than CD patients without MetS. Methods: We conducted a retrospective cohort study of CD patients seen from 2000 to 2012 at our tertiary care center. We analyzed crude and age-, sex- and duration of CD-adjusted incidence rate ratio (IRR) of CD-related hospitalization of those with MetS versus those without MetS. We also investigated possible associations between individual component conditions of MetS and rate of CD-related hospitalization. Results: A total of 868 CD patients were included. There were 37 (4%) patients with MetS at initial observation. After multi-variable adjustment, patients with MetS had a CD-related hospitalization rate twice that of those who did not have MetS. High triglycerides (TG), low high density lipoprotein (HDL) cholesterol and diabetes mellitus (DM) were associated with increased risk of CD-related hospitalization. Conclusions: CD patients with MetS have a higher rate of CD-related hospitalization compared to those without MetS. Hypertriglyceridemia, low HDL cholesterol and DM may be good markers of local and systemic inflammation as seen in CD.

KW - Crohn's disease

KW - Diabetes mellitus

KW - Dyslipidemia

KW - Hospitalization rate

KW - Hypertension

KW - Inflammatory bowel disease

KW - Inflammatory markers

KW - Metabolic co-morbidities

KW - Metabolic syndrome

KW - Obesity

UR - http://www.scopus.com/inward/record.url?scp=84926165254&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84926165254&partnerID=8YFLogxK

U2 - 10.1159/000380763

DO - 10.1159/000380763

M3 - Article

C2 - 25833139

AN - SCOPUS:84926165254

VL - 91

SP - 257

EP - 262

JO - Digestion

JF - Digestion

SN - 0012-2823

IS - 3

ER -